| Code | Description | Claims | Beneficiaries | Total Paid |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,972 |
987 |
$44K |
| 80053 |
Comprehensive metabolic panel |
4,054 |
3,890 |
$37K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,998 |
1,969 |
$28K |
| 80061 |
Lipid panel |
2,348 |
2,342 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,194 |
2,994 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
403 |
396 |
$14K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
377 |
251 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
908 |
904 |
$12K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
214 |
214 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
1,906 |
1,779 |
$12K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
92 |
92 |
$11K |
| 87428 |
|
217 |
216 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,255 |
1,250 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
225 |
221 |
$9K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
68 |
68 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
364 |
356 |
$5K |
| 84439 |
|
558 |
551 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
214 |
214 |
$3K |
| 81001 |
|
978 |
929 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
127 |
77 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
119 |
119 |
$2K |
| 87634 |
|
18 |
17 |
$1K |
| 0011A |
|
26 |
26 |
$984.10 |
| 97161 |
|
14 |
14 |
$771.01 |
| 0012A |
|
19 |
19 |
$719.15 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
42 |
37 |
$370.92 |
| 85027 |
|
27 |
27 |
$133.75 |
| 87210 |
|
13 |
12 |
$62.66 |
| 91301 |
|
67 |
67 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
806 |
694 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
93 |
85 |
$0.00 |